Astrazenecas Sglt2 Inhibitors Study Has Positive Implications For India: Dr Dalal | Latest News RSS feed

Astrazenecas Sglt2 Inhibitors Study Has Positive Implications For India: Dr Dalal - Latest News


AstraZeneca's CVD-REAL study has positive implications for India: Dr Dalal

AstraZeneca's CVD-REAL study involving SGLT-2 inhibitors (SGLT-2i) has a positive implication for management of ... of CV death and all-cause mortality by 60-80 per cent, said Dr. Dalal. India has ove... read more

Vivus, Inc. (VVUS)

Yes ☐ No ☒ Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (o... read more

Vivus, Inc. (VVUS)

Yes ☐ No ☒ Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (o... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us